Push to Add Weight-Loss Drugs to PBS Subsidy Scheme
Health Minister Mark Butler confirms a push to list drugs like Wegovy on the PBS, potentially saving thousands for Australians with obesity. Read the latest.
Health Minister Mark Butler confirms a push to list drugs like Wegovy on the PBS, potentially saving thousands for Australians with obesity. Read the latest.
Leading gold miners including Newmont, Greatland Gold, and Capricorn Metals see share prices fall sharply. Discover the market forces and analyst insights behind the plunge.
Western Australia's top lithium stocks surged $2.8 billion in value on Tuesday, driven by a sharp price recovery and strong demand for battery metals. Discover the key players and market forces.
Rio Tinto's share price surged to a record, driven by a strategic lithium acquisition and strong iron ore prices. Discover how the mining giant's counter-cyclical move is now delivering major returns.
A Townsville family's desperate fight for a lifesaving cancer drug is stalled by PBS bureaucracy. Their plea highlights systemic delays affecting patients across Australia. Read their story.
Charger Metals leads ASX runners with a 105% surge on gold discovery. Calix and Investigator Silver also post big gains on lithium tech and silver prices. Explore the week's top performers.
Millions of Australians will save on prescription costs as PBS co-payments drop to $31.60 from New Year's Day. Find out how the federal government's policy affects you.
The Australian share market delivered a subdued performance in 2025, trailing major global indices. Discover the key factors behind the ASX's lag and what it means for investors.
Western Australian gold miners and a lithium revival led the ASX in 2025, with some stocks tripling in value. Discover the top performers and what drove the market.
A unique Perth industrial property, where liquid cocaine is legally made for surgery, has sold for a multi-million dollar sum. The pharmaceutical tenant remains. Read the exclusive details.
The ASX small-cap sector exploded in 2025, driven by a gold boom, silver's 140% surge, and geopolitical tailwinds. Discover the year's top performers and what 2026 may hold.
ADX Energy readies a busy 2026 with Welchau-1 flow testing in February and three shallow gas wells planned. A pivotal period for the Perth junior's European ambitions.
Western Australian gold stocks have dominated the ASX200's best performers in 2025, delivering average gains of 159.5% as bullion soars. Discover the top companies and market outlook for 2026.
Kaili Resources rocketed 39,650% in 2025's ASX frenzy. Discover the year's top performers, from gold majors to critical minerals stars, and the sectors that took a beating. Get the full analysis.
A Kambah mother fights for PBS reform so her sons with Crohn's can access biologics, a first-line treatment in other OECD nations, instead of 18 tablets daily. #Health #Crohns #Australia
Liquidators have won court approval to investigate Creso Pharma's former packagers as they pursue over $20 million owed to creditors. Get the full details on the legal pursuit.
The WA Government announces a permanent commercial fishing ban and extended recreational closures to rescue critically depleted demersal fish stocks. Find out how this impacts you.
Mayne Pharma's stock plummeted 20% after the government removed key products from the PBS. Discover the full impact on investors and the pharmaceutical sector.
European Metals Holdings rockets 150% after securing $645 million EU grant for Cinovec lithium project. Discover how this transforms Europe's battery supply chain and other ASX winners.
Western Australia's rapid population growth is putting unprecedented pressure on fish stocks. Industry leader Trevor Whittington warns of potential decimation without immediate action.
Treasurer Jim Chalmers blocks US firm's takeover of South Australian pharmaceutical company, citing national interest in healthcare security. Read the full details.
Brazilian copper explorer Alvo Minerals rockets 178% after hitting massive sulphides just 40m below surface. Discover why this junior miner leads our ASX runners in a volatile market week.
QCoal founder Chris Wallin quietly increases Venus Metals stake to 26.21% as the company's exposure to Youanmi gold project and royalty stream gains momentum. Discover the strategic moves.
Dominique Roth battles rare CTX disease but the life-changing drug costs $500,000 annually. Her story highlights urgent need for PBS reforms to help Australians with rare conditions.
Zoono Group leads ASX gainers with 178% surge after major packaging deals. ReNerve, Stealth Group and Havilah Resources also post strong gains amid market volatility. Discover this week's top performers.
Broadcasting legend Sandy Roberts celebrates as a $440,000 myeloma drug is added to the PBS, costing patients under $32. A game-changer for cancer treatment in Australia.
DroneShield defends $70 million share sell-off by CEO and directors that stunned investors, sending the anti-drone company's stock plunging over 30%. Learn the full story.
Alarming 400% increase in ADHD medication poisonings reported in Australia over past decade. Experts warn of growing prescription rates and accidental overdoses.
Discover which ASX-listed companies delivered explosive growth this week, from mineral explorers to tech innovators making waves in Australian markets.
ASX-listed PacGold achieves remarkable exploration success, hitting gold mineralization in every drill hole at their Queensland target, signalling potential major discovery.